Related Experiment Videos

Dysfunctional voiding in children secondary to internal sphincter dyssynergia: treatment with phenoxybenzamine

Insights

Internal sphincter dyssynergia, a voiding disorder in children, was defined using urodynamic evaluation. Treatment with phenoxybenzamine, an alpha-adrenergic sympatholytic agent, proved successful in resolving this condition.

Area of Science:

  • Pediatric Urology
  • Urodynamics
  • Clinical Medicine

Background:

  • Dysfunctional voiding is a common issue in pediatric urology.
  • Internal sphincter dyssynergia presents as a clinical challenge in pediatric patients.
  • Urodynamic evaluation is crucial for diagnosing voiding disorders.

Purpose of the Study:

  • To define and categorize internal sphincter dyssynergia in children.
  • To investigate the efficacy of phenoxybenzamine in treating this condition.

Main Methods:

  • Urodynamic evaluation was employed to assess bladder and sphincter function.
  • Patients diagnosed with internal sphincter dyssynergia were treated with phenoxybenzamine.
  • Clinical outcomes were monitored to determine treatment success.

Main Results:

  • Internal sphincter dyssynergia was successfully defined and categorized.
  • Phenoxybenzamine treatment demonstrated significant success in the studied patient cohort.
  • The alpha-adrenergic sympatholytic agent effectively managed the obstructive voiding disorder.

Conclusions:

  • Internal sphincter dyssynergia is a distinct clinical entity in pediatric voiding dysfunction.
  • Phenoxybenzamine is an effective therapeutic option for children with internal sphincter dyssynergia.
  • Urodynamic assessment is vital for accurate diagnosis and management planning.

Related Concept Videos